Here are the latest quarterly results of DR. LAL PATHLABS. For more details, see the DR. LAL PATHLABS financial fact sheet and DR. LAL PATHLABS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,894 | 4,910 | 5,410 | 6,013 | 5,389 | 5,454 | 6,019 | 6,602 | |
Other income | Rs m | 105 | 142 | 144 | 181 | 183 | 184 | 206 | 219 | |
Turnover | Rs m | 4,999 | 5,052 | 5,554 | 6,194 | 5,572 | 5,638 | 6,225 | 6,821 | |
Expenses | Rs m | 3,764 | 3,754 | 3,948 | 4,235 | 3,983 | 4,007 | 4,319 | 4,577 | |
Gross profit | Rs m | 1,130 | 1,156 | 1,462 | 1,778 | 1,406 | 1,447 | 1,700 | 2,025 | |
Depreciation | Rs m | 379 | 376 | 351 | 359 | 360 | 366 | 347 | 353 | |
Interest | Rs m | 91 | 90 | 80 | 78 | 70 | 66 | 60 | 60 | |
Profit before tax | Rs m | 765 | 832 | 1,175 | 1,522 | 1,159 | 1,199 | 1,499 | 1,831 | |
Tax | Rs m | 229 | 263 | 339 | 415 | 337 | 341 | 421 | 523 | |
Profit after tax | Rs m | 536 | 569 | 836 | 1,107 | 822 | 858 | 1,078 | 1,308 | |
Gross profit margin | % | 23.1 | 23.5 | 27.0 | 29.6 | 26.1 | 26.5 | 28.2 | 30.7 | |
Effective tax rate | % | 29.9 | 31.6 | 28.9 | 27.3 | 29.1 | 28.4 | 28.1 | 28.6 | |
Net profit margin | % | 11.0 | 11.6 | 15.5 | 18.4 | 15.3 | 15.7 | 17.9 | 19.8 | |
Diluted EPS | Rs | 6.4 | 6.8 | 10.0 | 13.2 | 9.8 | 10.3 | 12.9 | 15.6 | |
Diluted EPS (TTM) | Rs | 29.5 | 28.8 | 31.9 | 36.5 | 39.9 | 43.3 | 46.2 | 48.6 | |
Subscriber Feature |
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.